Abbott, CA, Malik, RA, van Ross, ERE, Kulkarni, J, Boulton, AJM. Prevalence and characteristics of painful diabetic neuropathy in a large community-based diabetic population in the U.K. Diabetes Care. 2011;34:2220-2224.
Zilliox, L, Russell, JW. Treatment of diabetic sensory polyneuropathy. Curr Treat Options Neurol. 2011;13:143-159.
Schmader, KE. Epidemiology and impact on quality of life of postherpetic neuralgia and painful diabetic neuropathy. Clin J Pain. 2002;18:350-354.
Dyck, PJ, Albers, JW, Andersen, H, et al. Toronto Expert Panel on Diabetic Neuropathy. Diabetic polyneuropathies: update on research definition, diagnostic criteria and estimation of severity. Diabetes Metab Res Rev. 2011;27:620-628.
Tesfaye, S, Boulton, AJ, Dyck, PJ, et al. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care. 2010;33:2285-2293.
Veves, A, Backonja, M, Malik, RA. Painful diabetic neuropathy: epidemiology, natural history, early diagnosis, and treatment options. Pain Med. 2008;9:660-674.
Daousi, C, Benbow, SJ, Woodward, A, MacFarlane, IA. The natural history of chronic painful peripheral neuropathy in a community diabetes population. Diabet Med. 2006;23:1021-1024.
Griebeler, ML, Morey-Vargas, OL, et al. Pharmacologic interventions for painful diabetic neuropathy. An umbrella systematic review and comparative effectiveness network meta-analysis. Ann Intern Med. 2014;161:639-649.
Finnerup, NB, Sindrup, SH, Jensen, TS. The evidence for pharmacological treatment of neuropathic pain. Pain. 2010;150:573-581.
Attal, N, Cruccu, G, Baron, R, et al. European Federation of Neurological Societies. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 Revision. Eur J Neurol. 2010;17:1113-1123.
Bril, V, England, J, Franklin, GM, et al. American Academy of Neurology. Evidence-based guideline: treatment of painful diabetic neuropathy: report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. Neurology. 2011;76:1758-1765.
Rothwell, PM. External validity of randomised controlled trials: “To whom do the results of this trial apply?”. Lancet. 2005;365:82-93.
Moulin, DE, Clark, AJ, Gordon, A, et al. Long-term outcome of the management of chronic neuropathic pain: a prospective observational study. J Pain. 2015;16:852-861.
American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetic Care. 2005;28(suppl 1):S37-S42.
Bouhassira, D, Attal, N, Alchaar, H, et al. Comparison of pain syndromes associated with nervous and somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain. 2005;114:29-36.
Dworkin, RH, Turk, DC, Farrar, JT, et al. Core outcome measures for chronic Pain Clinical Trials: IMMPACT Recommendations. Pain. 2005;113:9-19.
Archer, AG, Watkins, PJ, Thomas, PK, Sharma, AK, Payan, J. The natural history of acute painful neuropathy in diabetes mellitus. J Neurol Neurosurg Psychiatry. 1983;46:491-499.
Thibault, P, Loisel, P, Durand, MJ, Catchlove, R, Sullivan, MJ. Psychological predictors of pain expression and activity intolerance in chronic pain patients. Pain. 2008;139:47-54.
Eisenberg, E, McNicol, E, Carr, DB. Opioids for neuropathic pain. Cochrane Database Syst Rev. 2006:CD006146.
Rivat, C, Ballantyne, J. The dark side of opioids in pain management: basic science explains clinical observation. PAIN Rep. 2016;1:e570.
Franklin, GM. Opioids for chronic noncancer pain: a position paper of the American Academy of Neurology. Neurology. 2014;83:1277-1284.
Ballantyne, JC, Shin, NS. Efficacy of opioids for chronic pain: a review of the evidence. Clin J Pain. 2008;24:469-478.
Cleeland, CS, Ryan, KM. Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singapore. 1994;23:129-138.
Keller, S, Bann, CM, Dodd, SL, Schein, J, Mendoza, TR, Cleeland, CS. Validity of the brief pain inventory for use in documenting the outcomes of patients with noncancer pain. Clin J Pain. 2004;20:309-318.
Gilron, I, Bailey, JM, Tu, D, Holden, RR, Weaver, DF, Houlden, RL. Morphine, gabapentin or their combination for neuropathic pain. N Engl J Med. 2005;352:1324-1334.
Gilron, I, Bailey, JM, Tu, D, Holden, RR, Jackson, AC, Houlden, RL. Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomized controlled crossover trial. Lancet. 2009;374:1252-1261.
Gilron, I, Tu, D, Holden, RR, Jackson, AC, DuMerton-Shore, D. Combination of morphine with nortriptyline for neuropathic pain. Pain. 2015;156:1440-1448.